Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

silent stories

Cholangiocarcinoma – Disease Awareness

BackgroundCholangiocarcinoma (CCA) is a rare type of bile duct cancer, and it’s the second most common primary liver cancer in the world. Unfortunately, patients with CCA historically have limited treatment...

The Good Ideas Group

Cell and gene therapies as depicted via a DNA strand

The fast-paced future of cell and gene therapies

In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist...

Avalere Health

Create Health's latest recruits gathered in the agency's Bristol studio

Healthcare marketing agency Create Health continues to grow

Eight new recruits, including Business Development Director, Marketing Manager and Medical Writer join Create Health.

Create Health

Bedrock new starters

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications

- PMLiVE

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

Avalere Health

- PMLiVE

Lifting the fog to help Clinical Labs navigate IVDR 2022

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers...

Create Health

- PMLiVE

Reframing rare to increase earlier diagnosis of Gaucher Disease

Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...

Create Health

- PMLiVE

Creating a monster to distrupt the market and solve a chronic problem

ConvaTec launched AQUACEL Ag+ in 2014, a new class of dressing proven to disrupt and destroy biofilm. They came to us to help them position AQUACEL Ag+ as the solution...

Create Health

- PMLiVE

Inspiring researchers to find the impossible with a next generation solution

Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to...

Create Health

- PMLiVE

Empowering the GP to help women feel the vagisil prohydrate difference

Vagisil were launching their first product available on prescription. It was a tough task to put Vagisil ProHydrate front of mind and turn GPs into advocates. That’s why they came...

Create Health

- PMLiVE

Are your field teams ready to excel in the new era?

A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs.

The Creative Engagement Group

5 Healthcare Marketing Blunders | How To Avoid Them.

5 Healthcare Marketing Blunders | How To Avoid Them.

Here are 5 healthcare marketing blunders and how best to avoid them.

The Good Ideas Group

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links